Wordt geladen...
Neutralizing antibodies against SARS-CoV-2: current understanding, challenge and perspective
The rapid emergence of Coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2) as a pandemic that presents an urgent human health crisis. Many SARS-CoV-2 neutralizing antibodies (NAbs) were developed with efficient therapeutic potential. NAbs-based...
Bewaard in:
Gepubliceerd in: | Antib Ther |
---|---|
Hoofdauteurs: | , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Oxford University Press
2020
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799234/ https://ncbi.nlm.nih.gov/pubmed/33912797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/abt/tbaa028 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|